|
CO5180550A1
(es)
|
1999-04-19 |
2002-07-30 |
Smithkline Beecham Corp |
Inhibidores de fab i
|
|
CO5370679A1
(es)
|
1999-06-01 |
2004-02-27 |
Smithkline Beecham Corp |
Inhibidores fab 1
|
|
US6730684B1
(en)
|
1999-10-08 |
2004-05-04 |
Affinium Pharmaceuticals, Inc. |
Fab I inhibitors
|
|
US6762201B1
(en)
|
1999-10-08 |
2004-07-13 |
Affinium Pharmaceuticals, Inc. |
Fab I inhibitors
|
|
HU230030B1
(hu)
|
1999-10-08 |
2015-05-28 |
Debiopharm International Sa |
Fab I inhibitorok
|
|
EP1560584B1
(en)
*
|
2001-04-06 |
2009-01-14 |
Affinium Pharmaceuticals, Inc. |
Fab i inhibitors
|
|
EP1575951B1
(en)
*
|
2002-12-06 |
2014-06-25 |
Debiopharm International SA |
Heterocyclic compounds, methods of making them and their use in therapy
|
|
WO2004082586A2
(en)
|
2003-03-17 |
2004-09-30 |
Affinium Pharmaceuticals, Inc. |
Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
|
|
DK1828167T3
(da)
*
|
2004-06-04 |
2014-10-20 |
Debiopharm Int Sa |
Acrylamidderivater som antibiotiske midler
|
|
KR20080075027A
(ko)
*
|
2005-12-05 |
2008-08-13 |
아피늄 파마슈티컬스, 인크. |
Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
|
|
KR20080114711A
(ko)
*
|
2006-03-02 |
2008-12-31 |
아스텔라스세이야쿠 가부시키가이샤 |
17β ＨＳＤ 타입 5 저해제
|
|
JP5468899B2
(ja)
|
2006-07-20 |
2014-04-09 |
アフィニウム ファーマシューティカルズ， インク． |
Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
|
|
EP2125802A4
(en)
|
2007-02-16 |
2014-08-20 |
Debiopharm Int Sa |
SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
|
|
WO2012064642A1
(en)
*
|
2010-11-08 |
2012-05-18 |
Glaxosmithkline Llc |
Fatty acid synthase inhibitors
|
|
AU2013279021C1
(en)
|
2012-06-19 |
2017-03-16 |
Debiopharm International Sa |
Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
|
|
ES2753386T3
(es)
|
2013-03-13 |
2020-04-08 |
Forma Therapeutics Inc |
Derivados de 2-hidroxi-1-{4-[(4-fenil)fenil]carbonil}piperazin-1-il}etano-1-ona y compuestos relacionados como inhibidores de sintasa de ácido graso (FASN) para el tratamiento del cáncer
|
|
RS61312B1
(sr)
|
2016-02-26 |
2021-02-26 |
Debiopharm Int Sa |
Lek za lečenje infekcija dijabetskog stopala
|
|
WO2019199979A1
(en)
*
|
2018-04-10 |
2019-10-17 |
The General Hospital Corporation |
Antibacterial compounds
|
|
TWI767148B
(zh)
|
2018-10-10 |
2022-06-11 |
美商弗瑪治療公司 |
抑制脂肪酸合成酶(fasn)
|
|
US10793554B2
(en)
|
2018-10-29 |
2020-10-06 |
Forma Therapeutics, Inc. |
Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone
|
|
TN2021000159A1
(en)
|
2019-02-14 |
2023-04-04 |
Debiopharm Int Sa |
Afabicin formulation, method for making the same and uses thereof
|
|
SG11202113174SA
(en)
|
2019-06-14 |
2021-12-30 |
Debiopharm Int Sa |
Medicament and use thereof for treating bacterial infections involving biofilm
|